首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Acute peritoneal dialysis in neonates with acute kidney injury and hypernatremic dehydration
【24h】

Acute peritoneal dialysis in neonates with acute kidney injury and hypernatremic dehydration

机译:新生儿急性肾损伤和高钠血症性脱水的急性腹膜透析

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: We aimed to evaluate the efficacy of acute peritoneal dialysis (PD) and clinical outcomes in neonates with acute kidney injury (AKI) and hypernatremic dehydration. Methods: The medical records of 15 neonates with AKI and hypernatremic dehydration who were treated with acute PD were reviewed. The diagnoses were AKI with hypernatremic dehydration with or without sepsis in 13 patients and AKI with hypernatremia and congenital nephropathy in 2 patients. The main indications for PD were AKI with some combination of oligoanuria, azotemia, hyperuricemia, and metabolic acidosis unresponsive to initial intensive medicaltreatment. Results: The mean age of the patients at dialysis initiation was 11.9 ± 9 days, and the mean duration of PD was 6.36 ± 4.8 days. In 7 patients (46.7%), hypotension required the use of vasopressors, and in 6 patients (40%), mechanical ventilation was required. Peritoneal dialysis-related complications occurred in 7 patients (46.7%), the most common being catheter malfunction (n = 6). Four episodes of peritonitis occurred in the 15 patients (26.7%), 2 episodes in patients with congenital renal disease and 2 episodes in patients with sepsis and multiorgan failure, who did not survive. Congenital renal disease, septicemia, and the need for mechanical ventilation were important factors influencing patient survival. All patients with no pre-existing renal disease or sepsis recovered their renal function and survived. Conclusions: In neonates with AKI and hypernatremic dehydration, PD is safe and successful, and in patients without congenital renal disease or sepsis, the prognosis is good. Peritoneal dialysis should be the treatment of choice in neonates with AKI and hypernatremic dehydration who do not respond to appropriate medical treatment.
机译:目的:我们旨在评估急性腹膜透析(PD)在新生儿急性肾损伤(AKI)和高钠血症性脱水中的疗效。方法:回顾性分析急性PD治疗的15例AKI合并高钠血症脱水的新生儿的病历。诊断为AKI伴有或不伴有败血症的高钠血症性脱水13例,2例伴有高钠血症和先天性肾病的AKI。 PD的主要适应症是AKI,伴有少尿,尿毒症,高尿酸血症和代谢性酸中毒,对初始强化治疗无反应。结果:透析开始时患者的平均年龄为11.9±9天,PD的平均持续时间为6.36±4.8天。在7例患者(46.7%)中,低血压需要使用血管加压药;在6例患者(40%)中,需要机械通气。腹膜透析相关并发症发生在7例患者中(46.7%),最常见的是导管功能不全(n = 6)。 15例患者中有4例腹膜炎(占26.7%),先天性肾脏疾病患者中有2例发生,败血症和多器官功能衰竭患者中有2例没有生存。先天性肾脏疾病,败血病和需要机械通气是影响患者生存的重要因素。所有没有肾脏疾病或败血症的患者均恢复了肾功能并幸存。结论:对于AKI合并高钠血症脱水的新生儿,PD是安全,成功的,对于无先天性肾脏疾病或败血症的患者,预后良好。对于没有适当药物治疗的AKI和高钠血症性脱水新生儿,应选择腹膜透析治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号